GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Opyl Ltd (ASX:OPL) » Definitions » Notes Receivable

Opyl (ASX:OPL) Notes Receivable : A$0.00 Mil (As of Dec. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Opyl Notes Receivable?

Opyl's Notes Receivable for the quarter that ended in Dec. 2024 was A$0.00 Mil.


Opyl Notes Receivable Historical Data

The historical data trend for Opyl's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Opyl Notes Receivable Chart

Opyl Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Opyl Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Opyl Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Opyl Notes Receivable Related Terms

Thank you for viewing the detailed overview of Opyl's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Opyl Business Description

Traded in Other Exchanges
N/A
Address
6 Middlemiss Street, Milsons Point, Sydney, NSW, AUS, 2000
Opyl Ltd is engaged in the development of its digital tools that improve clinical trials, healthcare experience for patients, deliver deep market insights from social media data, and improve the efficiency and value of the clinical research process. It invests in research and develops technologies as well as provides digital tools and insights services to healthcare, wellness, and science technology-focused clients.

Opyl Headlines

No Headlines